0,943  0,003  Antioxidant
0,934  0,005  Alpha-glucosidase inhibitor
0,915  0,003  Free radical scavenger
0,904  0,005  Antidiabetic
0,904  0,005  Cyclophilin D inhibitor
0,891  0,004  Chemoprotective
0,876  0,008  Apoptosis agonist
0,820  0,004  UGT1A9 substrate
0,815  0,004  Hypoglycemic
0,804  0,003  Hepatoprotectant
0,800  0,004  Hepatic disorders treatment
0,798  0,004  Apoptosis antagonist
0,799  0,004  UGT1A6 substrate
0,784  0,018  Antiinflammatory
0,768  0,007  Antiobesity
0,765  0,007  Chemopreventive
0,760  0,005  Nitric oxide antagonist
0,747  0,001  Cyclooxygenase 3 inhibitor
0,728  0,004  UDP-glucuronosyltransferase substrate
0,717  0,004  Antineoplastic enhancer
0,727  0,017  Antineoplastic (breast cancer)
0,714  0,004  Wound healing agent
0,714  0,004  UGT1A1 substrate
0,708  0,005  Histamine release inhibitor
0,696  0,006  Proliferative diseases treatment
0,689  0,005  Antimutagenic
0,677  0,023  Transcription factor NF kappa B inhibitor
0,659  0,007  AR expression inhibitor
0,634  0,003  SULT1A3 substrate
0,623  0,008  Cardioprotectant
0,594  0,005  Genotoxic
0,594  0,005  Antidiabetic symptomatic
0,578  0,004  Protein kinase A inhibitor
0,574  0,012  Lipoprotein disorders treatment
0,562  0,003  DNA polymerase I inhibitor
0,563  0,026  Antibacterial
0,549  0,014  NOS2 expression inhibitor
0,549  0,015  NOS3 expression inhibitor
0,548  0,017  Mutagenic
0,538  0,009  Vascular (periferal) disease treatment
0,522  0,007  Antiulcerative
0,520  0,005  Sulfotransferase substrate
0,527  0,017  Antiischemic
0,505  0,003  Antihemorrhagic
0,547  0,045  Caspase 9 stimulant
0,494  0,010  Myocardial infarction treatment
0,514  0,037  15-Lipoxygenase inhibitor
0,485  0,013  Antihypertriglyceridemic
0,473  0,008  UGT1A3 substrate
0,463  0,007  Lipid peroxidase inhibitor
0,461  0,005  Liver fibrosis treatment
0,459  0,005  Antialcoholic
0,488  0,042  Antileukemic
0,471  0,027  Antifungal
0,442  0,006  NOS3 expression enhancer
0,438  0,003  Creatine kinase inhibitor
0,443  0,010  Skin whitener
0,456  0,040  Prostate cancer treatment
0,445  0,031  Cytotoxic
0,441  0,029  Antiosteoporotic
0,439  0,030  Antineoplastic (cervical cancer)
0,412  0,006  UGT2B1 substrate
0,414  0,011  Melanin inhibitor
0,433  0,034  Caspase 3 stimulant
0,439  0,053  CYP3A4 substrate
0,414  0,046  Bone diseases treatment
0,392  0,033  Antidiabetic (type 2)
0,384  0,027  Amyloid beta aggregation inhibitor
0,354  0,003  Viral attachment inhibitor
0,369  0,029  Antineoplastic (liver cancer)
0,359  0,022  Antineoplastic (sarcoma)
0,344  0,008  M18 aspartyl aminopeptidase inhibitor
0,342  0,007  Cystathionine beta-synthase inhibitor
0,372  0,038  UGT2B4 substrate
0,367  0,037  Antiprotozoal (Leishmania)
0,338  0,013  UGT2B15 substrate
0,392  0,067  Immunosuppressant
0,326  0,003  Lipase inhibitor
0,393  0,080  TNF expression inhibitor
0,360  0,048  CYP1A2 substrate
0,317  0,010  Toxic, respiratory center
0,345  0,042  Antipyretic
0,330  0,031  GST M1-1 substrate
0,314  0,015  Neurotrophic factor enhancer
0,321  0,022  UGT2B7 substrate
0,338  0,039  Superoxide dismutase inhibitor
0,349  0,053  Spasmolytic
0,334  0,039  Antineoplastic (glioblastoma multiforme)
0,297  0,005  Protein kinase C mu inhibitor
0,329  0,044  Platelet antagonist
0,322  0,041  Vasodilator
0,330  0,050  Antineoplastic (osteosarcoma)
0,340  0,060  Antineoplastic (ovarian cancer)
0,330  0,050  Antineoplastic (glioma)
0,333  0,056  CTGF expression inhibitor
0,348  0,080  Antineoplastic (lung cancer)
0,273  0,007  Carbonic anhydrase III inhibitor
0,308  0,043  Carcinogenic
0,284  0,020  Diabetic nephropathy treatment
0,298  0,035  Platelet adhesion inhibitor
0,306  0,047  Hypolipemic
0,279  0,021  Cyclooxygenase inhibitor
0,276  0,021  Monophenol monooxygenase inhibitor
0,288  0,034  Antihypotensive
0,265  0,013  Antineoplastic antibiotic
0,260  0,008  Carbonic anhydrase VI inhibitor
0,298  0,050  Angiogenesis stimulant
0,308  0,062  Hypoxia-inducible factor 1 alpha inhibitor
0,298  0,052  Cytostatic
0,263  0,023  Topoisomerase II inhibitor
0,248  0,009  Estrogen antagonist
0,245  0,007  Estrogen receptor beta antagonist
0,255  0,019  Cyclooxygenase 2 inhibitor
0,273  0,037  Antiviral (Influenza)
0,252  0,016  Protein-tyrosine phosphatase 1B inhibitor
0,294  0,063  Antihypercholesterolemic
0,236  0,005  Papain-like protease (SARS coronavirus) inhibitor
0,273  0,043  Antiviral (HIV)
0,256  0,029  Protein-tyrosine phosphatase inhibitor
0,285  0,066  Teratogen
0,232  0,014  Carbonic anhydrase XV inhibitor
0,242  0,028  Prostate disorders treatment
0,239  0,028  Antiviral (Influenza A)
0,223  0,022  Glutathione S-transferase substrate
0,293  0,094  ICAM1 expression inhibitor
0,312  0,116  Antiprotozoal
0,202  0,008  Aromatase inhibitor
0,208  0,015  Constipation treatment
0,192  0,005  Estrogen receptor beta agonist
0,200  0,013  Histidine decarboxylase inhibitor
0,225  0,039  Protein kinase C nu inhibitor
0,189  0,008  SULT1E1 substrate
0,230  0,053  Antihelmintic
0,185  0,009  Estrogen agonist
0,221  0,045  Prostatic (benign) hyperplasia treatment
0,266  0,095  Antineoplastic (colorectal cancer)
0,172  0,004  Fatty acid synthase inhibitor
0,237  0,076  Embryotoxic
0,211  0,053  UGT1A4 substrate
0,255  0,097  Lipoxygenase inhibitor
0,197  0,041  UGT2B9 substrate
0,194  0,053  Antihelmintic (Nematodes)
0,216  0,078  RNA-directed DNA polymerase inhibitor
0,145  0,010  Thioredoxin reductase inhibitor
0,194  0,065  VEGF expression inhibitor
0,135  0,009  Protein kinase C eta inhibitor
0,189  0,065  LDLR expression enhancer
0,205  0,083  Antiparasitic
0,152  0,035  Gastritis treatment
0,226  0,109  5 Hydroxytryptamine uptake stimulant
0,171  0,055  Amylase inhibitor
0,131  0,015  Estrogen receptor alpha antagonist
0,114  0,004  Prolyl endopeptidase inhibitor
0,222  0,112  CYP2C19 substrate
0,121  0,013  Antiviral (Hepatitis A)
0,183  0,077  P-glycoprotein inhibitor
0,119  0,015  Postmenopausal disorders treatment
0,144  0,040  Antineoplastic (uterine cancer)
0,109  0,008  Estrogen receptor alpha agonist
0,101  0,003  Apical sodium codependent bile acid transporter inhibitor
0,136  0,038  HDL-cholesterol increasing
0,212  0,115  Antineoplastic (colon cancer)
0,144  0,048  Cholesterol synthesis inhibitor
0,248  0,151  CYP2C9 substrate
0,100  0,005  Squalene epoxidase inhibitor
0,158  0,064  Hair growth stimulant
0,091  0,003  Sodium/glucose cotransporter inhibitor
0,113  0,029  Antibiotic
0,117  0,034  Protein kinase C zeta inhibitor
0,130  0,049  Antiviral (Influenza B)
0,085  0,004  Sodium/glucose cotransporter 2 inhibitor
0,173  0,093  Antiarrhythmic
0,114  0,035  Thioredoxin inhibitor
0,123  0,046  Xanthine oxidase inhibitor
0,141  0,066  Antiacne
0,126  0,051  SULT1A1 substrate
0,150  0,078  Interferon gamma antagonist
0,122  0,051  Protein kinase C gamma inhibitor
0,115  0,044  Anabolic
0,161  0,091  Antineoplastic (gastric cancer)
0,185  0,118  Nitric-oxide synthase stimulant
0,069  0,003  Sodium/glucose cotransporter 1 inhibitor
0,132  0,070  Interleukin 4 antagonist
0,139  0,077  Protein kinase stimulant
0,140  0,082  Antidote
0,185  0,128  DNA damaging
0,074  0,018  Postcoital contraceptive
0,101  0,045  Actinic keratosis treatment
0,108  0,057  Toll-Like receptor 4 antagonist
0,058  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,177  0,129  Antineoplastic (renal cancer)
0,085  0,039  SULT1A2 substrate
0,098  0,053  ABCA1 expression enhancer
0,106  0,062  Beta glucuronidase inhibitor
0,147  0,105  Sensitization
0,175  0,136  Immunostimulant
0,070  0,031  Xanthine dehydrogenase inhibitor
0,098  0,061  UGT2B11 substrate
0,068  0,032  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,065  0,031  Carbonic anhydrase VB inhibitor
0,047  0,013  Cholesterol absorption inhibitor
0,115  0,083  Acetylcholinesterase inhibitor
0,066  0,035  Transcription factor AP-1 inhibitor
0,104  0,074  Electron transport complex I inhibitor
0,100  0,070  Topoisomerase I inhibitor
0,073  0,043  Carbonic anhydrase VA inhibitor
0,078  0,053  NAD(P)H dehydrogenase (quinone) inhibitor
0,043  0,020  Arginase inhibitor
0,069  0,047  SULT2A1 substrate
0,050  0,028  Carbonic anhydrase VII inhibitor
0,075  0,054  Carbonic anhydrase XIII inhibitor
0,196  0,174  Angiogenesis inhibitor
0,092  0,071  Phosphodiesterase 6D inhibitor
0,194  0,176  Antineoplastic (brain cancer)
0,095  0,077  AMP-activated protein kinase stimulant
0,140  0,122  UGT2B10 substrate
0,173  0,156  Respiratory analeptic
0,034  0,019  Estrogen-related receptor beta antagonist
0,064  0,049  Carbonic anhydrase V inhibitor
0,068  0,055  Telomerase inhibitor
0,073  0,061  Antitreponemal
0,061  0,050  Transcription factor RelA inhibitor
0,156  0,146  Antineoplastic (non-small cell lung cancer)
0,151  0,141  Pneumotoxic
0,200  0,190  Interleukin 2 agonist
0,048  0,041  Aldose reductase inhibitor
0,068  0,062  Na+ K+ transporting ATPase inhibitor
0,028  0,022  RNA-directed RNA polymerase stimulant
0,064  0,059  Protein kinase C beta inhibitor
0,027  0,022  1,3-Beta-glucan synthase inhibitor
0,128  0,123  Diabetic retinopathy treatment
0,055  0,050  Lipocortins synthesis agonist
0,149  0,149  Antiamyloidogenic
0,161  0,161  Analeptic

